According to a new market report published by Lucintel, the future of the esoteric testing market looks promising with opportunities in the independent and reference laboratories and hospital laboratories. The esoteric testing market is expected to grow with a CAGR of 12% from 2019 to 2024. The major drivers for this market are rising geriatric population and subsequent growth in the prevalence of chronic diseases, increasing burden of infectious diseases, rising demand for early disease detection using specialized diagnostic tests, growing awareness of personalized medicine, and increasing funding and research grants for the development of innovative esoteric tests.
Different types of test are performed to detect the disease, such as infectious diseases testing, endocrinology testing, oncology testing, immunology testing, genetic testing, toxicology testing, and neurology testing. Infectious diseases is the largest segment of the esoteric testing market.
Chemiluminescence immunoassay (CLIA), enzyme-linked immunosorbent assay (ELISA), mass spectrometry, real time – PCR, flow cytometry, and radioimmunoassay, are the major techniques of the esoteric testing market.
North America will remain the largest region over the forecast period due to increasing number of research activities in healthcare, growing investment in healthcare by major market players, and increasing patient population suffering from chronic diseases.
Labcorp, Quest Diagnostics, Opko Health, Miraca, Myriad Genetics, Sonic Healthcare, Primary Health Care, Healthscope, Foundation Medicine, ACM Global Laboratories, Arup Laboratories, Fulgent Genetics, Invitae, Mayo Medical Laboratories, and Spectra Laboratories are among the major players of esoteric testing.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the esoteric testing market by product type, technology, end user, and region. Lucintel has prepared a comprehensive research report titled " Esoteric Testing Market 2019-2024: Trends, Forecast, and Opportunity Analysis" .The Lucintel report serves as a catalyst for growth strategy as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the esoteric testing market by product type, technology, end user, and region as follows:
By Product Type [$M shipment analysis for 2013 – 2024]:
• Infectious Diseases Testing
• Endocrinology Testing
• Oncology testing
• Immunology Testing
• Genetic Testing
• Toxicology Testing
• Neurology Testing
• Others
By Technology [$M shipment analysis for 2013 – 2024]:
• Chemiluminescence Immunoassay (CLIA)
• Enzyme-linked Immunosorbent Assay (ELISA)
• Mass Spectrometry
• Real Time – PCR
• Flow Cytometry
• Radioimmunoassay
• Others
By End User [$M shipment analysis for 2013 – 2024]:
• Independent and Reference Laboratories
• Hospital Laboratories
By Region [$M shipment analysis for 2013 – 2024]:
• North America
o United States
o Canada
o Mexico
• Europe
o United Kingdom
o Germany
o France
o Italy
o Spain
• Asia-Pacific
o China
o India
o Japan
• ROW
o Brazil
A report of more than 150 pages will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link…… or [email protected].
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
This report addresses the following key questions:
Q.1. What are some of the most promising potential, high-growth opportunities for the esoteric testing market by product type (infectious diseases testing, endocrinology testing, oncology testing, immunology testing, genetic testing, toxicology testing, neurology testing, and others), technology (chemiluminescence immunoassay (CLIA), enzyme-linked immunosorbent assay (ELISA), mass spectrometry, real time – PCR, flow cytometry, radioimmunoassay, and others), end user (independent and reference laboratories and hospital laboratories), and region (North America, Europe, Asia-Pacific, and ROW)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which regions will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the drivers and challenges of the esoteric testing market?
Q.5. What are the business risks and threats to the esoteric testing market?
Q.6. What are emerging trends in this esoteric testing market and the reasons behind
them?
Q.7. What are some changing demands of customers in the esoteric testing market?
Q.8. What are the new developments in the esoteric testing market? Which companies
are leading these developments?
Q.9. Who are the major players in this esoteric testing market? What strategic initiatives are being implemented by key players for business growth?
Q.10. What are some of the competitive products and processes in this esoteric testing area and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11. What M & A activities have taken place in the last 5 years in this ,esoteric testing market?